Last reviewed · How we verify
packed red blood cells transfusion
At a glance
| Generic name | packed red blood cells transfusion |
|---|---|
| Sponsor | Rania Ali El-Farrash |
| Modality | Biologic |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Biological Parameters Changes After Autologous Blood Transfusion of Red Blood Cells (200 ml) in Healthy Volunteers. (NA)
- Blood Storage Related Mortality and Adverse Effects in Trauma Patients
- Evaluating the Effects of Hemoglobin Threshold-specific Packed Red Blood Cell Transfusions on Quality of Life and Functional Outcomes in Patients With High-grade Myeloid Neoplasms, Acute Myeloid Leukemia, or B Acute Lymphoblastic Lymphoma/Leukemia (NA)
- Evaluation of a Transfusion Therapy Using Whole Blood in the Management of Coagulopathy in Patients With Acute Traumatic Hemorrhage (PHASE3)
- S-Nitrosylation (SNO) Therapy During Autologous Blood Transfusion (PHASE1)
- WithHolding Enteral Feeds Around Blood Transfusion (International) (NA)
- Mechanisms Affecting the Gut of Preterm Infants Receiving Blood Transfusion With Different Enteral Feed Interventions
- The Correlation Between Red Cell Transfusion and Complications of Prematurity
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- packed red blood cells transfusion CI brief — competitive landscape report
- packed red blood cells transfusion updates RSS · CI watch RSS
- Rania Ali El-Farrash portfolio CI